6-(3,7-Dimethylocta-2,6-dienyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 黄酮类化合物
• 英文名称: 6-(3,7-Dimethylocta-2,6-dienyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one
• 化学式: C₂₅H₂₈O₅
• 分子量: 408.5
• InChiKey: XYIQIBWIEGCVQY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.2
• 重原子数：
  30
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  87
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• Prenylflavanone compounds for modulating diabetes
  申请人：NatureWise Biotech & Medicals Corporation

  公开号：EP2783684A1

  公开（公告）日：2014-10-01

  The present invention is directed to a novel use of prenylflavanone compounds for control of blood glucose and treatment or prevention of diabetes.

  本发明涉及一种控制血糖和治疗或预防糖尿病的前黄烷酮化合物的新用途。
• PRENYLFAVANONE COMPOUNDS AND USES THEREOF
  申请人：Huang Chung-Yang

  公开号：US20100144856A1

  公开（公告）日：2010-06-10

  The present invention relates to new prenylflavanone compounds and a pharmaceutical composition comprising at least one of the compounds.
• PRENYLFLAVANONE COMPOUNDS AND USES THEREOF
  申请人：Huang Chung-Yang

  公开号：US20100144857A1

  公开（公告）日：2010-06-10

  The present invention relates to new prenylflavanone compounds and a pharmaceutical composition comprising at least one of the compounds.
• PRENYLFLAVANONE COMPOUNDS FOR MODULATING DIABETES
  申请人：NATUREWISE BIOTECH & MEDICALS CORPORATION

  公开号：US20140296543A1

  公开（公告）日：2014-10-02

  The present invention is directed to a novel use of prenylflavanone compounds for control of blood glucose and treatment or prevention of diabetes.
• US9457007B2
  申请人：——

  公开号：US9457007B2

  公开（公告）日：2016-10-04